3 Einträge gefunden

1. Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials

   1. Reich, K
   2. DeLozier, A M
   3. Nunes, F P
   4. Thyssen, J P
   5. Eichenfield, L F
   6. Wollenberg, A
   7. Ross Terres, J A

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

   1. Wollenberg, A
   2. Nakahara, T
   3. Maari, C
   4. Peris, K
   5. Lio, P
   6. Augustin, M
   7. Silverberg, J I

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

   1. Simpson, E L
   2. Lacour, J-P
   3. Spelman, L
   4. Galimberti, R
   5. Eichenfield, L F
   6. Bissonnette, R
   7. King, B A

   2020 - Forschungsinformationssystem des UKE